Search

Purpose: To assess the need for routine transposition of an anterior crossing vessel during dismembered laparoscopic pyeloplasty., Patients and Methods: We reviewed data from 70 patients who were undergoing laparoscopic pyeloplasty at our institution from March 2000 to December 2004 for ureteropelvic junction (UPJ) obstruction. An anterior crossing vessel was identified intraoperatively in 31 (44%) patients. The decision to transpose was made by the surgeon's intraoperative perception of the obstructive nature of the mobilized vessel after UPJ dismemberment. Outcomes between the groups who were undergoing transposition of the vessel (n = 8) were retrospectively compared with the group not undergoing transposition (n = 23). Success was defined by symptom resolution and evidence of improved drainage on diuretic renographic or urographic imaging., Results: All 31 patients had resolution of obstruction. Both groups were similar as regards preoperative and postoperative differential function and t(1/2) on diuretic renography. The laparoscopic approach, however, was significantly different between the two groups. The majority of patients (87.5%) in whom the vessel was transposed underwent transperitoneal laparoscopic pyeloplasty. In contrast, the majority of patients (74%) in whom the vessel was not transposed underwent retroperitoneoscopic pyeloplasty (P = 0.004). As such, only 1 of 18 (6%) patients who were treated retroperitoneally received a vessel transposition compared with 7 of 13 (54%) of patients in whom the surgery was transperitoneally., Conclusions: During laparoscopic pyeloplasty, routine transposition of an anterior crossing vessel may be unnecessary. The decision to transpose appears to be governed by the surgeon's subjective intraoperative assessment and the choice of laparoscopic approach to facilitate technical ease of reconstruction.

Objectives: To examine the feasibility of using laser energy during nerve-sparing robotically assisted radical prostatectomy (RARP), as the energy sources currently used for haemostasis in RARP adversely affect cavernous nerve function, while clips require application by a skilled assistant, but laser energy potentially allows precise dissection with minimal collateral tissue injury., Materials and Methods: We used laser-based RARP in 10 dogs, using the da Vinci S system (Intuitive Surgical, Sunnyvale, CA, USA) and a prototype robotic laser instrument. The potassium-titanyl-phosphate laser was used for dissection at 2-6 W, with intermittent use of the neodymium-doped yttrium-aluminium-garnet laser at 5 W for coagulating larger vessels. The peak intracavernosal pressure response to nerve stimulation was recorded as a percentage of mean arterial pressure (ICP%MAP) before and after RARP. Five dogs were killed immediately after RARP and five were maintained alive for 72 h; the haemoglobin and haematocrit levels were measured before and after RARP in the latter five dogs., Results: All 10 procedures were performed solely using laser energy and no additional haemostatic manoeuvres. The median prostate excision time was 65 min. The ICP%MAP before and after RARP (median 98.5% and 77.0%, P = 0.12) were not significantly different; similarly, the respective haemoglobin (median 14.4 vs 12.6 g/dL, P = 0.06) and haematocrit levels (45.1% vs 40.2%, P = 0.06) were not significantly different. Two dogs had catheter-related complications and one had an anastomotic leak. There were no laser-related complications or postoperative haemorrhage., Conclusions: Laser RARP is feasible in dogs and further assessment is warranted.

Objectives: To compare the long-term oncologic and renal function outcomes in patients undergoing laparoscopic (LRN) versus open radical nephrectomy (ORN)., Methods: The medical records of 116 patients undergoing radical nephrectomy for pathologically confirmed renal cell carcinoma before January 2000 were reviewed. Of these 116 patients, 63 underwent LRN and 53 ORN. The oncologic and renal functional data were obtained from the patient charts, radiographic reports, and direct telephone calls to the patients or their families., Results: The median follow-up was 65 months (range 19 to 92) in the LRN group and 76 months (range 8 to 105) in the ORN group. LRN was successfully completed in all patients without open conversion. The mean tumor size was 5.4 cm in the LRN group and 6.4 cm in the ORN group (P = 0.007). The 5-year overall survival (78% versus 84%, respectively; P = 0.24), cancer-specific survival (91% versus 93%, respectively; P = 0.75), and recurrence-free survival (91% versus 93%, respectively; P = 0.75) rates were similar between the LRN and ORN groups. At 7 years, the overall survival (72% versus 84%; P = 0.24), cancer-specific survival (91% versus 93%; P = 0.75), and recurrence-free survival (91% versus 93%; P = 0.75) rates were also comparable. No port site recurrence was noted in the laparoscopic group. The long-term renal function outcomes were similar in the LRN and ORN groups, with serum creatinine increasing by 33% and 25%, and the estimated creatinine clearance decreasing by 31% and 23% from baseline, respectively. Chronic renal insufficiency developed in 4% of patients in each group., Conclusions: The results of our study have shown that LRN and ORN have comparable long-term oncologic and renal functional outcomes.

Objectives: To present outcomes of laparoscopic partial nephrectomy (LPN) in patients with compromised baseline renal function., Methods: Of 485 patients undergoing LPN between September 1999 and August 2005 at our institution, 48 (10%) had compromised baseline renal function, defined as serum creatinine 1.5mg/dL or greater (group I). Outcomes were compared with 437 patients undergoing LPN with normal baseline renal function (serum creatinine less than 1.5 mg/dL, group II). Both groups were compared regarding perioperative data, complications, and renal functional and oncologic outcomes., Results: Group i patients were older (67.6 versus 58.6 years, P <0.001) and had higher American Society of Anesthesiologists scores (2.8 versus 2.4, P <0.001), higher Charlson Comorbidity Index (1.9 versus 0.7, P <0.001), and larger tumors (3.3 versus 2.7 cm, P = 0.01). Intraoperative data, postoperative outcomes, overall complications, and pathologic data were similar between groups. At a mean follow-up of 21 months, the deterioration in serum creatinine and estimated glomerular filtration rate was similar between groups (P = 0.99 and 0.89, respectively). Dialysis was required in 5 patients (10%) in group I and 3 patients (0.6%) in group II (P <0.001). Within group I, older patients (older than 70 years) with prolonged warm ischemia (greater than 30 minutes) had significantly worse renal functional outcomes. Comparing groups I and II, estimated 5-year overall survival was 78% versus 90% (log rank = 0.01) and cancer-specific survival was 100% versus 98% (log rank = 0.65)., Conclusions: Older patients with compromised renal function and warm ischemia time greater than 30 minutes are at high risk for renal dysfunction after LPN. Alternate nephron-sparing methods including hypothermia or probe-ablation should be considered in these patients.

Purpose: We present our experience with and the technique of laparoscopic mesh reconstruction or suture repair of intentional resection or intraoperative injury of the diaphragm., Materials and Methods: In a 10-year (1997 to 2006) review of 1,850 upper abdominal renal and/or adrenal laparoscopic procedures at our institution 13 patients (0.7%) sustained diaphragmatic entry, including iatrogenic injury in 7 (0.4%), deliberate laparoscopic excision of a portion of the diaphragm in 2 and diaphragmatic incision during transthoracic adrenalectomy in 4. Laparoscopic repair techniques involved primary suture repair in 11 cases and primary reconstruction with a synthetic graft in 2. A rubber catheter and water seal system were used to primarily evacuate the pneumothorax., Results: Inadvertent diaphragmatic injury in 7 cases occurred during transperitoneal (6) and retroperitoneal (1) laparoscopy, including partial nephrectomy in 4, radical nephrectomy in 2 and adrenalectomy in 1. A diaphragmatic breach occurred due to hook electrocautery in 5 cases, trocar insertion in 1 and liver retraction in 1. Deliberate diaphragmatic excision and mesh reconstruction in 2 cases were performed after en bloc excision of the diaphragm during radical nephrectomy in 1 and during excision of a metastatic diaphragmatic nodule in 1. Four transthoracic transdiaphragmatic adrenalectomies were completed successfully without any intraoperative complications. All cases were completed laparoscopically without open conversion. A chest tube was placed prophylactically in the initial 2 patients undergoing transthoracic transdiaphragmatic adrenalectomy., Conclusions: Laparoscopic and transthoracic repair/reconstruction of the diaphragm is safe and effective.

Objectives: Techniques for laparoscopic radical cystectomy are rapidly evolving. The entire procedure can be performed completely intracorporeally by pure laparoscopic techniques or by open-assisted laparoscopic techniques in which the urinary diversion is constructed extracorporeally by way of a minilaparotomy incision. We retrospectively evaluated the outcomes of these two techniques with a focus on perioperative outcomes and associated morbidity., Methods: From December 1999 to March 2006, 54 patients underwent laparoscopic radical cystectomy for muscle invasive (n = 35) or high-risk non-muscle-invasive (n = 19) bladder cancer. The mean follow-up was 25 months (range, 1 to 66 months)., Results: Of the 54 patients, 17 underwent a pure laparoscopic (group 1, 8 conduit and 9 neobladder) and 37 underwent an open-assisted laparoscopic (group 2, 18 conduit and 19 neobladder) procedure. No significant differences were noted between the groups in patient age, comorbidities, or pathologic stage of malignancy. Group 2 was superior with regard to operative time, blood loss, transfusion rate, time to oral intake, time to ambulation, and postoperative complications (P <0.05 for all comparisons). Anastomotic leak, bowel obstruction, or sepsis requiring reexploration developed in 5 patients (29%) in group 1 and 4 patients (11%) in group 2. A "learning curve" was observed for both procedures, but it was particularly steep for the pure laparoscopic technique, and this approach was eventually abandoned., Conclusions: Laparoscopic radical cystectomy is associated with a learning curve, with morbidity largely resulting from the urinary diversion procedure. Our experience suggests that the open-assisted laparoscopic approach is technically more efficient and associated with a quicker recovery profile and decreased complication rates compared with the pure laparoscopic approach.

Robotic assisted radical prostatectomy (RARP) is gaining acceptance and popularity among urologists all over the world. Early oncologic and functional results are encouraging. In this manuscript, we describe in detail both approaches for RARP and show the results of the robotic surgery program with over 300 RARP performed at our institution.

Purpose: We determined the incidence of and risk factors for perioperative complications associated with laparoscopic oncological surgery for urological malignancy., Materials and Methods: All records of patients undergoing laparoscopic surgery for urological malignancy at a tertiary care institution from April 1997 through January 2006 were reviewed. Relevant demographic and perioperative data during and within 6 weeks of surgery were evaluated retrospectively. Various factors were analyzed to estimate risk of a perioperative complication such as the Charlson Comorbidity Index, American Society of Anesthesiologists score, European Scoring System for laparoscopic urological operations and surgeon experience. Logistic regression was used to identify independent risk factors for perioperative complications., Results: A total of 1,867 laparoscopic oncological surgeries were performed, including radical or partial nephrectomy, nephroureterectomy, radical prostatectomy and radical cystectomy. Perioperative complications occurred in 12.4% of patients, including 3.5% intraoperatively and 8.9% postoperatively. Intraoperative (2.3%) and postoperative hemorrhage (2.7%) accounted for 40% of all perioperative complications. All cause perioperative mortality occurred in 8 patients (0.4%). On multivariate analysis radical cystectomy (adjusted OR 4.9, p <0.001), partial nephrectomy (adjusted OR 2.4, p <0.001), length of surgery greater than 4 hours (adjusted OR 2.5, p <0.001) and preoperative serum creatinine greater than 1.5 mg/dl (adjusted OR 2.1, p = 0.04) were independent risk factors for perioperative complications. Comparing the periods of 1997 to 2000 vs 2001 to 2005, despite a significant increase in technical complexity of procedures (European Scoring System 9.8 vs 60.6, p <0.001), the incidence of complications tended to decrease (17.3% vs 12.5%, p = 0.3)., Conclusions: In appropriately selected patients laparoscopic urological oncological surgery is safe. These data on perioperative complications could possibly serve as a reference benchmark for practicing urologists.

Objectives: Laparoscopic partial nephrectomy (LPN) is a technically challenging procedure for the management of renal tumours. Major complications of LPN include bleeding and urine leakage. Haemostatic agents (HAs) and/or glues may reduce haemorrhage and urine leakage. We sought to examine the current practice patterns for urologists performing LPN with regard to HA use and its relationship with bleeding and urine leakage., Materials and Methods: A survey was sent via e-mail to urologists currently performing LPN in centres in the United States and Europe. We queried the indications for HA/glue usage, type of HAs/glues used, and whether concomitant suturing/bolstering was performed. In addition, the total number of LPNs performed, laparoscopic tools used to resect the tumour, tumour size, and tumour position were queried., Results: Surveys suitable for analysis were received from 18 centres (n=1347 cases). HAs and/or glues were used in 1042 (77.4%) cases. Mean tumour size was 2.8cm, with 79% of the tumours being defined as exophytic and 21% deep. The HAs and glues used included gelatin matrix thrombin (FloSeal), fibrin gel (Tisseel), bovine serum albumin (BioGlue), cyanoacrylate glue (Glubran), oxidized regenerated cellulose (Surgicel), or combinations of these. Sixteen centres performed concomitant suturing/bolstering. The overall postoperative bleeding requiring transfusion and urine leakage rates were 2.7% and 1.9%, respectively., Conclusions: The use of HAs and/or glues is routine in most centres performing LPN. The overall haemorrhage and urine leakage rates are low following LPN. More studies are needed to assess the potential role of HAs and/or glues in LPN., (European Association of Urology.)

Purpose: To report the 5-year oncological outcomes of patients undergoing laparoscopic radical nephrectomy for renal cancer compared to a cohort of patients undergoing open radical nephrectomy., Methods: We retrospectively analyzed the data of 88 patients undergoing radical nephrectomy for renal cell carcinoma prior to January 2000. Of these, 45 patients underwent laparoscopic radical nephrectomy, and 43 patients underwent open radical nephrectomy. Inclusion criteria comprised clinically organ-confined tumors of 15 cm or less in size without concomitant lymphadenopathy or vena cava thrombus. Oncological follow-up data were obtained from charts, radiological reports, and phone calls to patients or their families, and were calculated from the date of surgery to the date of last appointment with physician or date of death., Results: All laparoscopic procedures were completed without open conversion. On comparing the laparoscopic radical nephrectomy and open radical nephrectomy groups, mean tumor size was 5. 8 vs 6.2 cm (P = . 44), mean blood loss was 183 vs 461 mL (P = . 004), and mean operative time was 2.8 vs 3.7 hrs (P < . 001). Over a mean follow-up of 5 years in the laparoscopic radical nephrectomy group and 6 years in the open radical nephrectomy group, the overall survival was 81% vs 79% (P = . 47), and cancer-specific survival was 90% vs 92% (P = . 70) , respectively., Conclusions: Laparoscopic radical nephrectomy for renal cancer confers equivalent 5-year oncological outcomes to those of open surgery.

Objectives: To report our experience with laparoscopic partial nephrectomy in obese (body mass index greater than 30 kg/m2) patients compared with a contemporary cohort of nonobese patients., Methods: From August 1999 to December 2004, 140 obese (group 1) and 238 nonobese (group 2) patients underwent laparoscopic partial nephrectomy at our institution. We compared the demographics, operative data, and perioperative complications of these two groups., Results: Group 1 had a significantly greater incidence of hypertension and diabetes. In groups 1 and 2, respectively, the mean estimated blood loss was 310 mL (range 50 to 1500) and 249 mL (range 50 to 2500), the mean operating time was 3.4 hours (range 2.5 to 6) and 3.4 hours (range 1.5 to 6), and the mean warm ischemia time was 31 minutes (range 15 to 51) and 32 minutes (range 12 to 60). Intraoperative complications occurred in 8 patients (5.7%) in group 1 and 20 (8%) in group 2 (P = 0.19), with a blood transfusion rate of 6% and 3%, respectively (P = 0.42). The postoperative complication rate was not significantly different between the two groups (13% versus 9%, P = 0.77). The mean hospital stay was 2.8 days (range 1 to 8) for group 1 and 3.5 days (range 1 to 32) for group 2. Retroperitoneal access was associated with a shorter operative time and hospital stay in both groups., Conclusions: Laparoscopic partial nephrectomy was performed safely in obese patients, with a perioperative complication rate similar to that of nonobese patients. The retroperitoneal approach was associated with a shorter operative time and hospital stay in the obese and nonobese patients.

Laparoscopic partial nephrectomy (LPN) has emerged as a viable alternative for the conventional open nephron-sparing surgery (NSS). So far, an adequate renal parenchymal cutting and hemostasis, as well as caliceal repair remains technically challenging. Numerous investigators have developed techniques using different energy sources to simplify the technically demanding LPN. Herein we review these energy sources, discussing perceived advantages and disadvantages of each technique.

The authors report the experience of a high-volume center with laparoscopic surgery in urological oncology, as well as a review of other relevant series. Laparoscopic outcomes in the treatment of adrenal, kidney, upper tract transitional cell carcinoma, bladder, prostate, and testicular malignancy are described in this review. Specific considerations as complications and port-site recurrence are also addressed. The authors concluded that the intermediate-term oncological data is encouraging and comparable to open surgery.

Purpose: LPN is frequently reserved for small, peripherally located tumors. Centrally located tumors typically require complex intracorporeal suturing and reconstruction with hilar clamping, which is a laparoscopically advanced maneuver given the constraints of renal ischemia. We retrospectively compared our experience with central vs peripheral tumors treated with LPN., Materials and Methods: Between January 2001 and March 2004, 363 patients underwent LPN for tumor. The tumor was located centrally in 154 patients and peripherally in 209. Central tumors were defined as tumors centrally extending into the kidney in direct contact with or invading into the pelvicaliceal system and/or renal sinus on preoperative 3-dimensional computerized tomography. Lesions with no contact with the pelvicaliceal system were classified as peripheral. Preoperative, intraoperative, postoperative and pathological data were compared., Results: Central tumors were larger (median 3 vs 2.4 cm, p < 0.001) and had larger specimens at surgery (median 43 vs 22 gm, p < 0.001) than peripheral tumors. Although blood loss was similar (median 150 cc), central tumors required longer warm ischemia time (median 33.5 vs 30 minutes, p < 0.001), operative time (median 3.5 vs 3 hours, p = 0.008) and hospital stay (median 67 vs 60 hours, p < 0.001). A positive cancer margin occurred in 1 patient per group. Median postoperative serum creatinine was similar (1.2 vs 1.1 mg/dl). Intraoperative and late postoperative complications were comparable. However, more early postoperative complications occurred in the central group (6% vs 2%, p = 0.05)., Conclusions: LPN for central tumors can be performed safely by an experienced laparoscopic surgeon with perioperative outcomes comparable to those of peripheral tumors. Given the requisite laparoscopic expertise, indications for LPN should be expanded to include centrally located tumors.

Purpose: We report our experience with LPN for tumor in a solitary kidney., Materials and Methods: Of 430 patients undergoing LPN since February 1999 at our institution 22 (5%) underwent LPN for tumor in a solitary kidney, as performed by a single surgeon. The laparoscopic technique that we used duplicated open principles, including hilar clamping, cold cut tumor excision and sutured renal reconstruction., Results: Mean tumor size was 3.6 cm (range 1.4 to 8.3, median 3 cm), median blood loss was 200 cc (range 50 to 500), warm ischemia time was 29 minutes (range 14 to 55), total operative time was 3.3 hours (range 2.2 to 4.5) and hospital stay was 2.8 days (range 1.3 to 12). Two cases (9%) were electively converted to open surgery. Pathological findings confirmed renal cell carcinoma in 16 patients (73%) with negative surgical margins in all those with LPN. Major complications occurred in 3 patients (15%) and minor complications developed in 7 (32%). Median preoperative and postoperative serum creatinine (1.2 and 1.5 mg/dl) and estimated glomerular filtration rate (67.5 and 50 ml per minute per 1.73 m2) reflected a change of 33% and 27%, respectively, which appeared proportionate to the median amount of kidney parenchyma excised (23%). One patient (4.5%) required temporary hemodialysis. At a median followup of 2.5 years (range 0.5 to 4.5) cancer specific and overall survival was 100% and 91%, respectively. No patient with LPN had local or port site recurrence, or metastatic disease., Conclusions: LPN can be performed efficaciously and safely in select patients with tumor in a solitary kidney. To our knowledge we present the largest series in the literature. Advanced laparoscopic experience and expertise are necessary in this high risk population.

Purpose: Partial nephrectomy for hilar tumors represents a technical challenge not only for laparoscopic, but also for open surgeons. We report the technical feasibility and perioperative outcomes of laparoscopic partial nephrectomy (LPN) for hilar tumors., Materials and Methods: Between January 2001 and September 2004, 25 of 362 patients (6.9%) undergoing LPN for tumor, as performed by a single surgeon, had a hilar tumor. We defined hilar tumor as a tumor located in the renal hilum that was demonstrated to be in actual physical contact with the renal artery and/or renal vein on preoperative 3-dimensional computerized tomography. En bloc hilar clamping with cold excision of the tumor, including its delicate mobilization from the renal vessels, followed by sutured renal reconstruction was performed routinely., Results: Laparoscopic surgery was successful in all cases without any open conversions or operative re-interventions. Mean tumor size was 3.7 cm (range 1 to 10.3), 4 patients (16%) had a solitary kidney and the indication for LPN was imperative in 10 patients (40%). Pelvicaliceal repair was performed in 22 patients (88%), mean warm ischemia time was 36.4 minutes (range 27 to 48), mean blood loss was 231 cc (range 50 to 900), mean total operative time was 3.6 hours (range 2 to 5) and mean hospital stay was 3.5 days (range 1.5 to 6.7). Histopathology confirmed renal cell carcinoma in 17 patients (68%), of whom all had negative margins. In 2002 or earlier hemorrhagic complications occurred in 3 patients (12%). No kidney was lost for technical reasons., Conclusions: LPN can be performed in select patients with a hilar tumor. The technical feasibility reported further extends the scope of LPN. To our knowledge the initial experience in the literature is reported.

Open partial nephrectomy is the gold standard nephron-sparing treatment for small renal tumors. Technical aspects of laparoscopic partial nephrectomy have evolved considerably, and the technique is approaching established status at our institution. Over the past 4 years, the senior author has performed more than 400 laparoscopic partial nephrectomies at the Cleveland Clinic. Herein we present our current technique and review contemporary outcome data.

Purpose: The oncological efficacy of partial nephrectomy is related to obtaining a negative surgical margin intraoperatively. This study assesses the oncological outcomes of patients undergoing laparoscopic partial nephrectomy for a renal tumor who had positive surgical margin on final pathology. Materials and Methods: The experiences of 2 surgeons with 511 patients with a pathological diagnosis of renal cell carcinoma treated with laparoscopic partial nephrectomy were reviewed. Patients with a positive surgical margin were identified retrospectively. Oncological outcomes were assessed by followup with chest x-ray and computerized tomography every 6 to 12 months for 5 years. Results: There were 9 patients (1.8%) with a positive margin on final pathology. Mean tumor size was 2.8 cm (range 1.7 to 4.0). Two patients underwent secondary completion radical nephrectomy, one at 4 days and the other at 2 months following laparoscopic partial nephrectomy. No residual tumor was identified in the nephrectomy specimen in either patient. Of the remaining 7 patients who elected surveillance, 1 with von Hippel-Lindau disease died of metastatic renal cell carcinoma to pancreas 10 months after laparoscopic partial nephrectomy. The remaining patients were disease-free for a median followup of 32 months (range 6 to 76). No patient in the series had port site seeding. Conclusions: A positive margin following laparoscopic partial nephrectomy does not necessarily indicate residual disease. However, vigilant monitoring is mandatory. While midterm outcomes parallel those of patients with a negative margin, longer followup is necessary to determine the ultimate oncological outcomes in this subgroup of patients. [Copyright &y& Elsevier]